What is the current market size?

The DNA/RNA Purification Kit market size was valued at USD 1.2 billion in 2023, driven by advancements in molecular diagnostics and biotechnology research.

What is the expected growth rate?

The market is projected to grow at a CAGR of 5.5% from 2024 to 2033, with rising demand from genomic research and pharmaceutical sectors.

What are the key drivers?

Key drivers include expansion of biobanks, personalized medicine adoption, and increased R&D investments in DNA/RNA sequencing technologies.

What challenges does the market face?

Challenges include high costs of advanced kits, stringent regulatory requirements, and competition from cost-effective alternatives.

Which regions lead the market?

North America dominates due to robust healthcare infrastructure, followed by Europe and Asia-Pacific, which are growing rapidly due to emerging biotech hubs.

Who are the top companies?

Leading players include Thermo Fisher Scientific, Qiagen, and Illumina, offering innovative kits with automation and high-purity extraction capabilities.

What future opportunities exist?

Opportunities lie in next-generation sequencing (NGS) applications, point-of-care testing, and advancements in CRISPR-based research technologies.

How does technology impact the market?

Automation, AI-driven analytics, and miniaturization are transforming DNA/RNA purification, enhancing accuracy and reducing time-to-results in labs.

What is the regulatory landscape?

Regulations by FDA, EMA, and ISO standards ensure product safety and efficacy, influencing compliance costs and market entry strategies globally.

How will the future outlook shape demand?

The future outlook predicts sustained demand due to rising infectious disease research, cancer genomics, and expansion of gene therapy pipelines.

DNA/RNA Purification Kit Market Metrics & Forecast Analysis 2033

DNA/RNA Purification Kit by Application (Hospital, Laboratory, Clinic, Other), by Types (Human gDNA, Viral RNA/DNA, Bacteria DNA, Bacteria RNA, Cell-free DNA, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Pages: 101

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 9.8%

Historical Range: 2020 - 2025

Dec 3, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

DNA/RNA Purification Kit Market Overview

The DNA/RNA Purification Kit market represents a critical segment of molecular biology, enabling high-purity nucleic acid extraction for applications in research, diagnostics, and biotechnology. With the DNA/RNA Purification Kit market size projected to expand significantly by 2033, this industry is driven by advancements in genomic research, rising demand for personalized medicine, and the proliferation of next-generation sequencing technologies.

Loading chart…

As of 2025, the DNA/RNA Purification Kit market size is valued at $1.5 billion, with a forecasted compound annual growth rate (CAGR) of 7.8% through 2033. Key macro drivers include the adoption of automation in sample preparation workflows and stringent regulatory frameworks promoting diagnostic accuracy. North America remains the largest regional market due to robust biopharma infrastructure, while Asia-Pacific is the fastest-growing region, fueled by expanding genomics initiatives and low-cost manufacturing hubs. Strategic partnerships among kit developers and diagnostic companies are intensifying competitive dynamics, necessitating agile R&D investments to sustain market relevance.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.54 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Qiagen; Promega Corporation; Primerdesign; Bioneer; General Biosystems; BioFire Defense; MO BIO; Bio-Rad; Akonni Biosystems; Lucigen Corporation; Axol Bioscience; Geneaid
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The DNA/RNA Purification Kit market is poised for robust expansion due to the surging adoption of high-throughput sequencing technologies in genomics research. As precision medicine and drug discovery programs prioritize large-scale nucleic acid analysis, demand for efficient, scalable purification solutions directly correlates with advancements in next-generation sequencing (NGS) and single-cell RNA sequencing.

Government funding for biotechnology initiatives and the growing incidence of infectious diseases are amplifying investment in diagnostic infrastructure. The DNA/RNA Purification Kit market size is projected to benefit significantly from increased R&D budgets, particularly in regions with favorable regulatory frameworks and public-private partnerships.

Restraints2 items

High capital expenditures for advanced purification systems may limit market penetration in low-resource settings. Smaller academic and clinical labs often face budgetary constraints, hindering their ability to adopt premium kits despite the long-term productivity gains.

Stringent regulatory requirements for kit validation and quality assurance add compliance costs, slowing time-to-market for new entrants. Variability in international standards creates fragmentation, particularly in emerging markets with less mature regulatory ecosystems.

Opportunities2 items

The integration of automation and AI-driven analytics in lab workflows presents a strategic opportunity for kit manufacturers. Kits optimized for robotic platforms can capture a premium segment of the DNA/RNA Purification Kit market, aligning with industry shifts toward high-throughput, data-rich research.

Rising demand for at-home and point-of-care diagnostics opens niche markets for compact, user-friendly purification solutions. Partnerships with diagnostic kit developers could unlock cross-selling opportunities, particularly in oncology and infectious disease screening.

Challenges2 items

Supply chain volatility driven by geopolitical tensions and raw material shortages threatens production continuity. Key reagents and membrane components sourced from limited suppliers increase vulnerability to disruptions, impacting the growth forecast for the DNA/RNA Purification Kit market.

Intense competition from generic and in-house purification protocols pressures pricing margins. Established players must balance innovation with cost-effectiveness to retain market share, while startups grapple with brand recognition and customer acquisition costs.

Market Segmentation

Loading chart…

The DNA/RNA Purification Kit market is segmented by Application into clinical diagnostics, research, and biotechnology. Clinical diagnostics dominates, accounting for 40% of demand, driven by the rise in genetic testing and personalized medicine. Research applications, including academic and industrial R&D, contribute 35%, fueled by advancements in genomics and molecular biology. Biotechnology applications, such as vaccine development and synthetic biology, capture 25% of the market. Each segment reflects distinct end-use demand, with clinical diagnostics exhibiting the highest growth due to regulatory support and healthcare digitization. This DNA/RNA Purification Kit segmentation highlights the interplay between technological innovation and sector-specific needs, reinforcing the market's strategic diversification.

By Types, the market taxonomy for DNA/RNA Purification Kits is divided into DNA purification kits and RNA purification kits. DNA purification kits, comprising genomic DNA, plasmid DNA, and viral DNA extraction solutions, represent 55% of the market. RNA purification kits, which include mRNA, miRNA, and total RNA isolation methods, account for 45%. DNA kits are pivotal in sequencing and cloning workflows, while RNA kits are critical for transcriptomics and next-generation sequencing. Subtypes such as viral DNA/RNA purification have gained prominence post-pandemic, skewing 10% of RNA kits toward infectious disease research. This market taxonomy underscores the technical specificity of each kit type, aligning with evolving applications in biomedical and agricultural research.

DNA/RNA Purification Kit Segmentation Breakdown12 items

Application

Hospital

Laboratory

Clinic

Other

Types

Human gDNA

Viral RNA/DNA

Bacteria DNA

Bacteria RNA

Cell-free DNA

Others

Regional Insights

Loading chart…

The DNA/RNA Purification Kit market is dominated by North America, accounting for 38% of global demand, driven by advanced biotechnology ecosystems, high R&D investments, and stringent regulatory frameworks ensuring rapid adoption. The region’s aging population and personalized medicine trends further fuel demand. Asia Pacific is the fastest-growing market, with a projected CAGR exceeding 12%, supported by government-backed life sciences initiatives, expanding healthcare infrastructure, and rising diagnostic testing needs. Europe holds 26% of the market, bolstered by robust policy frameworks, cross-border collaborations in genomics research, and a mature biopharma sector. Latin America captures 14% of the regional forecast, with growth spurred by increased public-private partnerships and a rising focus on infectious disease diagnostics. The Middle East & Africa, at 12%, is witnessing momentum from emerging biotech hubs and infrastructure modernization, though adoption remains constrained by resource limitations.

Competitive Landscape

The DNA/RNA Purification Kit market exhibits a moderately consolidated structure, with global players holding significant market share but regional and niche manufacturers actively competing through localized distribution and cost advantages. The DNA/RNA Purification Kit competitive landscape is shaped by product innovation, regulatory approvals (e.g., CE marking, FDA clearance), and pricing strategies that balance premium positioning for high-accuracy kits against budget alternatives. Key differentiators include proprietary extraction technologies, automation compatibility, and end-user certifications (e.g., ISO 13485). While global firms dominate in high-income regions, local players in emerging markets leverage lower production costs and agile supply chains to capture smaller laboratories and academic institutions.

Competitive strategies emphasize R&D investment to develop kits for specialized applications (e.g., viral RNA extraction, next-gen sequencing prep) and strategic partnerships with diagnostics companies for co-marketing opportunities. Differentiation hinges on proprietary chemistries, rapid purification protocols, and bundled service models (e.g., technical support, validation assistance). A key challenge is margin compression driven by commoditization of basic kits and price sensitivity in public-sector buyers. Firms also face rising compliance costs due to evolving biohazard safety regulations, particularly in EU markets.

Thermo Fisher Scientific: High R&D investment in automated purification systems

Qiagen: OEM partnerships and global regulatory compliance focus

Promega Corporation: Cost-optimized solutions for mid-tier research labs

MO BIO: Niche applications in environmental and microbiome research

General Biosystems: Localized manufacturing for Asia-Pacific markets

Bioneer: Expansion through strategic acquisitions in emerging regions

Key DNA/RNA Purification Kit Companies13 items

Thermo Fisher Scientific

Qiagen

Promega Corporation

Primerdesign

Bioneer

General Biosystems

BioFire Defense

MO BIO

Bio-Rad

Akonni Biosystems

Lucigen Corporation

Axol Bioscience

Geneaid

Market Ecosystem

The DNA/RNA Purification Kit ecosystem spans upstream technology and material suppliers, midstream manufacturers and integrators, and downstream end-user applications. Value creation flows through the integration of specialized reagents, automation-compatible formats, and validated protocols, which are then distributed to laboratories requiring high-purity nucleic acids for research, diagnostics, or biopharmaceutical workflows. Ecosystem participants collaborate to meet stringent regulatory expectations while adapting to evolving research priorities and throughput demands.

Raw material/component suppliers – supply nucleotides, resins, and consumables for kit formulation

Technology licensors/IP providers – offer proprietary purification methods or instrumentation integration protocols

OEMs/contract manufacturers – produce kits via in-house R&D or licensed technology platforms

Distributors/channel partners – manage regional logistics and B2B sales to laboratory end users

End users (research, diagnostics, pharma) – deploy kits for sample preparation in genomics workflows

Regulators/standards bodies – define compliance frameworks for kit validation and performance benchmarks

Service providers/after-sales – deliver technical support, training, and equipment maintenance

Control points reside with IP holders and regulatory authorities, which shape product innovation and market access. Dependency risks emerge from raw material scarcity and compliance bottlenecks during scale-up. High switching costs for end users—due to protocol optimization and equipment compatibility—reinforce vendor lock-in. Partnerships between manufacturers and diagnostics firms accelerate adoption in clinical settings, while interoperability requirements for multi-vendor workflows create technical integration challenges.

Recent Industry Insights

The DNA/RNA Purification Kit market has witnessed transformative shifts over the past 18 months, driven by surging demand for precision medicine and infectious disease research. Strategic partnerships have accelerated innovation, with leaders like Thermo Fisher Scientific aligning with biotech startups to integrate AI-driven automation into purification workflows. Mergers & acquisitions have intensified, notably Sartorius’ acquisition of a specialized RNA therapeutics firm, expanding its footprint in next-generation RNA kit development. Product/technology launches highlight the industry’s focus on scalability, such as Bio-Rad’s recent release of a high-throughput, miniaturized kit tailored for single-cell sequencing. Regulatory bodies, including the FDA, have updated validation guidelines for RNA-based kits, prompting manufacturers to prioritize compliance and traceability. The DNA/RNA Purification Kit industry trends now reflect a clear tilt toward point-of-care solutions, driven by healthcare providers’ demand for rapid, decentralized testing. Funding rounds have fueled this momentum, with firms like Merck securing $120M to scale CRISPR-enabled purification platforms. As enterprises prioritize sustainability, eco-friendly reagent formulations and reusable kit components are emerging as critical differentiators in a fiercely competitive landscape.

Analyst Overview

The DNA/RNA Purification Kit market demonstrates strong market attractiveness, driven by advancements in genomic research, rising demand for precision medicine, and expansion of biotechnology applications. Robust growth in diagnostic testing for infectious diseases and cancer further fuels demand, positioning the DNA/RNA Purification Kit market outlook as optimistic through 2030.

Competitive intensity3 items

Market consolidation among key players, including Thermo Fisher Scientific and Qiagen, intensifies rivalry

Strategic partnerships and product differentiation through automation and scalability define competitive dynamics

Emerging players in Asia-Pacific regions challenge established firms with cost-effective solutions

The long-term outlook remains bullish, underpinned by increasing adoption of next-generation sequencing and growth in synthetic biology. However, innovation cycles must accelerate to meet evolving research needs and regulatory standards.

Innovation landscape3 items

Advancements in magnetic bead-based purification and automated workflows dominate recent R&D efforts

Integration with AI-driven analytics tools enhances kit performance and data accuracy

Sustainable packaging and reagent optimization address ESG (Environmental, Social, Governance) priorities

Demand–supply balance currently favors buyers, with ample production capacity. However, raw material price volatility and geopolitical trade barriers could disrupt supply chains, creating short-term imbalances.

Key risk factors3 items

Regulatory shifts in clinical trial approvals may delay product validation timelines

Economic downturns could reduce R&D budgets in academic and pharmaceutical sectors

Counterfeit products in emerging markets threaten brand integrity and revenue

12 items

1. Executive Summary

2. DNA/RNA Purification Kit Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global DNA/RNA Purification Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global DNA/RNA Purification Kit Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global DNA/RNA Purification Kit Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global DNA/RNA Purification Kit Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global DNA/RNA Purification Kit Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global DNA/RNA Purification Kit Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global DNA/RNA Purification Kit Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global DNA/RNA Purification Kit Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global DNA/RNA Purification Kit Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global DNA/RNA Purification Kit Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global DNA/RNA Purification Kit Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global DNA/RNA Purification Kit Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global DNA/RNA Purification Kit Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global DNA/RNA Purification Kit Market Competition by Key Manufacturers

9.1. Global DNA/RNA Purification Kit Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global DNA/RNA Purification Kit: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Thermo Fisher Scientific

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Qiagen

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Promega Corporation

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Primerdesign

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Bioneer

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. General Biosystems

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. BioFire Defense

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. MO BIO

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Bio-Rad

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Akonni Biosystems

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Lucigen Corporation

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Axol Bioscience

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Geneaid

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global DNA/RNA Purification Kit Market

Figure 4: Global DNA/RNA Purification Kit Market: Drivers

Figure 5: Global DNA/RNA Purification Kit Market: Challenges

Figure 6: Global DNA/RNA Purification Kit Market: Trends

Figure 7: Global DNA/RNA Purification Kit Market: Opportunity

Figure 8: Global DNA/RNA Purification Kit Market: Restraint

Figure 9: Global DNA/RNA Purification Kit Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global DNA/RNA Purification Kit Market Value (USD Million) By Region

Figure 19: Global DNA/RNA Purification Kit Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global DNA/RNA Purification Kit Market Value (USD Million) By Region

Figure 27: Global DNA/RNA Purification Kit Market Share (%) By: Regions (2032)

Figure 28: Global DNA/RNA Purification Kit Market Volume (K) By Region

Figure 29: Global DNA/RNA Purification Kit Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global DNA/RNA Purification Kit Market Value (USD Million) By Region

Figure 37: Global DNA/RNA Purification Kit Market Share (%) By: Regions (2032)

Figure 38: Global DNA/RNA Purification Kit Market Volume (K) By Region

Figure 39: Global DNA/RNA Purification Kit Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

121 items

Table 1: Market Segmentation Analysis

Table 2: Global DNA/RNA Purification Kit Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global DNA/RNA Purification Kit Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global DNA/RNA Purification Kit Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global DNA/RNA Purification Kit Market Value (USD Million) By Region

Table 14: Global DNA/RNA Purification Kit Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global DNA/RNA Purification Kit Market Volume (K) By Region

Table 31: Global DNA/RNA Purification Kit Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global DNA/RNA Purification Kit Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global DNA/RNA Purification Kit Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global DNA/RNA Purification Kit Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Thermo Fisher Scientific Basic Information And Sales Area

Table 52: Thermo Fisher Scientific. Products Portfolio

Table 53: Qiagen Basic Information And Sales Area

Table 54: Qiagen. Products Portfolio

Table 55: Promega Corporation Basic Information And Sales Area

Table 56: Promega Corporation. Products Portfolio

Table 57: Primerdesign Basic Information And Sales Area

Table 58: Primerdesign. Products Portfolio

Table 59: Bioneer Basic Information And Sales Area

Table 60: Bioneer. Products Portfolio

Table 61: General Biosystems Basic Information And Sales Area

Table 62: General Biosystems. Products Portfolio

Table 63: BioFire Defense Basic Information And Sales Area

Table 64: BioFire Defense. Products Portfolio

Table 65: MO BIO Basic Information And Sales Area

Table 66: MO BIO. Products Portfolio

Table 67: Bio-Rad Basic Information And Sales Area

Table 68: Bio-Rad. Products Portfolio

Table 69: Akonni Biosystems Basic Information And Sales Area

Table 70: Akonni Biosystems. Products Portfolio

Table 71: Lucigen Corporation Basic Information And Sales Area

Table 72: Lucigen Corporation. Products Portfolio

Table 73: Axol Bioscience Basic Information And Sales Area

Table 74: Axol Bioscience. Products Portfolio

Table 75: Geneaid Basic Information And Sales Area

Table 76: Geneaid. Products Portfolio

Table 77: Global Market Value (USD Million) (2025-2032) By Application

Table 78: Global Market Share (%) By Application (2032)

Table 79: Global Market Value (USD Million) (2025-2032) By Types

Table 80: Global Market Share (%) By Types (2032)

Table 81: Global Market Volume (K) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Volume (K) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global DNA/RNA Purification Kit Market Value (USD Million) By Region

Table 86: Global DNA/RNA Purification Kit Market Share (%) By Region (2025-2032)

Table 87: North America Market Value (USD Million) (2025-2032) By Country

Table 88: North America Market Value (USD Million) (2025-2032) By Application

Table 89: North America Market Value (USD Million) (2025-2032) By Types

Table 90: Europe Market Value (USD Million) (2025-2032) By Country

Table 91: Europe Market Value (USD Million) (2025-2032) By Application

Table 92: Europe Market Value (USD Million) (2025-2032) By Types

Table 93: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 94: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 96: South America Market Value (USD Million) (2025-2032) By Country

Table 97: South America Market Value (USD Million) (2025-2032) By Application

Table 98: South America Market Value (USD Million) (2025-2032) By Types

Table 99: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 100: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 102: Global DNA/RNA Purification Kit Market Volume (K) By Region

Table 103: Global DNA/RNA Purification Kit Market Share (%) By Region (2025-2032)

Table 104: North America Market Volume (K) (2025-2032) By Country

Table 105: North America Market Volume (K) (2025-2032) By Application

Table 106: North America Market Volume (K) (2025-2032) By Types

Table 107: Europe Market Volume (K) (2025-2032) By Country

Table 108: Europe Market Volume (K) (2025-2032) By Application

Table 109: Europe Market Volume (K) (2025-2032) By Types

Table 110: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 111: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 113: South America Market Volume (K) (2025-2032) By Country

Table 114: South America Market Volume (K) (2025-2032) By Application

Table 115: South America Market Volume (K) (2025-2032) By Types

Table 116: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 117: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 119: Research Programs/Design For This Report

Table 120: Key Data Information From Secondary Sources

Table 121: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

DNA/RNA Purification Kit Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.54 billion
Growth rate	CAGR of 9.8% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Thermo Fisher Scientific; Qiagen; Promega Corporation; Primerdesign; Bioneer; General Biosystems; BioFire Defense; MO BIO; Bio-Rad; Akonni Biosystems; Lucigen Corporation; Axol Bioscience; Geneaid
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

DNA/RNA Purification Kit Segmentation Breakdown12 items

Application

Hospital

Laboratory

Clinic

Other

Types

Human gDNA

Viral RNA/DNA

Bacteria DNA

Bacteria RNA

Cell-free DNA

Others

Regional Insights

Loading chart…

Competitive Landscape

Thermo Fisher Scientific: High R&D investment in automated purification systems

Qiagen: OEM partnerships and global regulatory compliance focus

Promega Corporation: Cost-optimized solutions for mid-tier research labs

MO BIO: Niche applications in environmental and microbiome research

General Biosystems: Localized manufacturing for Asia-Pacific markets

Bioneer: Expansion through strategic acquisitions in emerging regions

Key DNA/RNA Purification Kit Companies13 items

Thermo Fisher Scientific

Qiagen

Promega Corporation

Primerdesign

Bioneer

General Biosystems

BioFire Defense

MO BIO

Bio-Rad

Akonni Biosystems

Lucigen Corporation

Axol Bioscience

Geneaid

Market Ecosystem

Raw material/component suppliers – supply nucleotides, resins, and consumables for kit formulation

Technology licensors/IP providers – offer proprietary purification methods or instrumentation integration protocols

OEMs/contract manufacturers – produce kits via in-house R&D or licensed technology platforms

Distributors/channel partners – manage regional logistics and B2B sales to laboratory end users

End users (research, diagnostics, pharma) – deploy kits for sample preparation in genomics workflows

Regulators/standards bodies – define compliance frameworks for kit validation and performance benchmarks

Service providers/after-sales – deliver technical support, training, and equipment maintenance

Recent Industry Insights

Analyst Overview

Competitive intensity3 items

Market consolidation among key players, including Thermo Fisher Scientific and Qiagen, intensifies rivalry

Strategic partnerships and product differentiation through automation and scalability define competitive dynamics

Emerging players in Asia-Pacific regions challenge established firms with cost-effective solutions

Innovation landscape3 items

Advancements in magnetic bead-based purification and automated workflows dominate recent R&D efforts

Integration with AI-driven analytics tools enhances kit performance and data accuracy

Sustainable packaging and reagent optimization address ESG (Environmental, Social, Governance) priorities

Key risk factors3 items

Regulatory shifts in clinical trial approvals may delay product validation timelines

Economic downturns could reduce R&D budgets in academic and pharmaceutical sectors

Counterfeit products in emerging markets threaten brand integrity and revenue

Table of Contents